HCA Healthcare (FRA:2BH) Equivalent Admissions #: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2BH HCA Healthcare Inc FRA:2BH
92 GF Score
Price €324.70
GF Value €396.26
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is HCA Healthcare Equivalent Admissions #?

HCA Healthcare FRA:2BH -1.01% 92 Equivalent Admissions # is 0.00 as of . 20. GuruFocus rates FRA:2BH with a GF Score™ of 92/100 and a GF Value™ of €396.26 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.

The historical rank and industry rank for HCA Healthcare's Equivalent Admissions # or its related term are showing as below:

FRA:2BH's Equivalent Admissions # is not ranked *
in the Healthcare Providers & Services industry.
Industry Median:
* Ranked among companies with meaningful Equivalent Admissions # only.

HCA Healthcare Equivalent Admissions # Historical Data

* Premium members only.

The historical data trend for HCA Healthcare's Equivalent Admissions # can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCA Healthcare Equivalent Admissions # Chart


FRA:2BH
92GF Score
HCA Healthcare Inc FRA:2BH
Equivalent Admissions # is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions
What does a Equivalent Admissions # of 0.00 mean?
HCA Healthcare (FRA:2BH) has a Equivalent Admissions # of 0.00 as of . 20. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on HCA Healthcare and its competitors.
Is HCA Healthcare's Equivalent Admissions # too high?
HCA Healthcare's current Equivalent Admissions # is 0.00. Overall, HCA Healthcare has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HCA Healthcare's Equivalent Admissions # compare to THC and DVA?
HCA Healthcare's Equivalent Admissions # of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equivalent Admissions # for a Healthcare Providers & Services company?
A good Equivalent Admissions # depends on the Healthcare Providers & Services industry context. However, Equivalent Admissions # should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equivalent Admissions # mean?
A high Equivalent Admissions # can signal that a stock is expensive relative to its fundamentals. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on HCA Healthcare and its competitors. HCA Healthcare's current Equivalent Admissions # is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCA Healthcare stock overvalued right now?
Based on GuruFocus' analysis, HCA Healthcare (FRA:2BH) is currently considered Modestly Undervalued. The stock's GF Value™ is €396.26, compared to a current price of €324.70 — trading 18.1% below its estimated fair value. The current Equivalent Admissions # is 0.00. HCA Healthcare's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equivalent Admissions # calculated?
Equivalent Admissions # is calculated from a company's financial statements. For HCA Healthcare (FRA:2BH), the current Equivalent Admissions # is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HCA Healthcare (FRA:2BH) Overvalued in 2026?

Based on GuruFocus' analysis, HCA Healthcare stock appears to be undervalued. The current stock price of €324.70 is trading 18.1% below its estimated GF Value™ of €396.26. GuruFocus considers HCA Healthcare to be Modestly Undervalued.

Key valuation signals for FRA:2BH:

  • Equivalent Admissions #: 0.00
  • GF Value™: €396.26 vs. price of €324.70 (18.1% below fair value)
  • GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the FRA:2BH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HCA Healthcare Business Description

Address One Park Plaza, Nashville, TN, USA, 37203
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
92GF Score

Get the complete analysis for FRA:2BH

Equivalent Admissions # is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€324.70
Price
€396.26
GF Value